A molecular diagnostics company wants to expand its new cartridge-based platform to help orthopedic surgeons make more informed care decisions for patients with a potential joint infection.
News & Features
Obalon Therapeutics, developer of the first FDA-approved swallowable, gas-filled balloon for obesity treatment, is preparing an underwritten public offering of its common stock.
The IRS and the U.S. Treasury Department have decided to give medical device companies relief from failure to deposit penalties for the first three quarters of 2018.
Scientists in Australia have developed an ingestible sensor to detect and measure gut gasses in the stomach. The data can be sent to a phone or computer and could change the way gut disorders are diagnosed and treated.
FDA and Zoll Medical are warning LifeVest 4000 patients to have the device replaced immediately if a specific error message appears on the screen of the wearable defibrillator.
The company recently prevailed in two separate legal battles; one involved a whistleblower lawsuit, and the other was over attorney fees from an old patent case.
General Electric is considering breakup options after taking a major tax hit related to an old portfolio of long-term care insurance.
FDA said it will delay implementing a rule put forth last year that would have changed how it determines the intended use of a medical product.
Lombard Medical Technologies has defaulted on a loan and said it doesn't have enough cash to survive past the first half of this year. Here's a look at how things went from bad to worse for Lombard.
AI, VR, and concept cars grabbed most of the headlines at this year's CES consumer electronics show in Las Vegas, but these medical technologies on display at the event could help make a real difference in people's lives.
Panelists at the recent J.P. Morgan Healthcare Conference in San Francisco, CA were charged with separating the hype from the reality in the field of diagnostics and offered insight into what products will win in the space.
Medtronic was one of four multinational companies chastised by Chinese regulators for referring to Taiwan as a country online.